APA
TAK icon

American Portfolios Advisors’s Takeda Pharmaceutical TAK Stock Holding History

American Portfolios Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$10.6K Hold
820
– – ﹤0.01% 2514
2022
Q2 		$11.5K Hold
820
– – ﹤0.01% 2502
2022
Q1 		$11.7K Hold
820
– – ﹤0.01% 2622
2021
Q4 		$11.2K Sell
820
-1,219
-60% -$17.1K ﹤0.01% 2582
2021
Q3 		$33.4K Hold
2,039
– – ﹤0.01% 2000
2021
Q2 		$34.3K Buy
2,039
+48
+2% +$817 ﹤0.01% 1932
2021
Q1 		$36.4K Buy
1,991
+972
+95% +$17.5K ﹤0.01% 1746
2020
Q4 		$18.5K Sell
1,019
-2,675
-72% -$46.9K ﹤0.01% 1850
2020
Q3 		$65.9K Buy
3,694
+2,694
+269% +$49.1K ﹤0.01% 1229
2020
Q2 		$17.9K Buy
1,000
+171
+21% +$3.07K ﹤0.01% 1685
2020
Q1 		$12.6K Sell
829
-70
-8% -$1.27K ﹤0.01% 1724
2019
Q4 		$17.7K Buy
899
+479
+114% +$9.16K ﹤0.01% 1772
2019
Q3 		$7.22K Buy
420
+219
+109% +$3.79K ﹤0.01% 2053
2019
Q2 		$3.56K Buy
201
+30
+18% +$546 ﹤0.01% 2295
2019
Q1 		$3.48K Buy
+171
New +$3.44K ﹤0.01% 2210

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

American Portfolios Advisors's TAK Position: Q3 2022 in Review

American Portfolios Advisors held its Takeda Pharmaceutical (TAK) position steady in Q3 2022 at 820 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2514.

American Portfolios Advisors first reported a position in TAK in Q1 2019 and has held it in 15 quarters since. The position peaked at $65.9K in Q3 2020. 277 funds tracked by Wall St. Rank hold TAK as of Q3 2022.

  • American Portfolios Advisors held 820 shares of Takeda Pharmaceutical worth $10.6K as of Q3 2022.
  • American Portfolios Advisors left its Takeda Pharmaceutical share count unchanged in Q3 2022.
  • Takeda Pharmaceutical made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2514 holding.
  • American Portfolios Advisors first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 15 quarters since.
  • American Portfolios Advisors's Takeda Pharmaceutical position peaked at $65.9K in Q3 2020.
  • 277 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.